Related Experiment Video
Updated: Sep 14, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot
Cara E Currier1, A M Bays2, J L Thomason3
1Elson S Floyd College of Medicine, Washington State University, Spokane, WA, USA.
Giant cell arteritis (GCA) diagnosis can be challenging with normal inflammatory markers like ESR and CRP. A longer delay in testing increases the likelihood of normal results, but GCA presentation remains similar.
Area of Science:
- Rheumatology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Giant cell arteritis (GCA) is a critical vasculitis requiring prompt diagnosis.
- Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) are key diagnostic markers, but some GCA patients exhibit normal levels.
- This variability necessitates exploring alternative diagnostic approaches when inflammatory markers are inconclusive.
Purpose of the Study:
- To compare the clinical presentation and vascular ultrasound findings in GCA patients with normal versus elevated inflammatory markers.
- To evaluate the diagnostic accuracy of ESR and CRP in detecting GCA.
- To identify factors associated with normal inflammatory markers in GCA patients.
Main Methods:
- Retrospective analysis of GCA patients diagnosed via a Fast Track Clinic (FTC).
- Comparison of clinical presentation and ultrasound results between GCA patients with normal (n=23) and elevated (n=107) inflammatory markers.
- Calculation of ESR and CRP sensitivity and specificity using an additional 159 non-GCA patients.
Main Results:
- C-Reactive Protein (CRP) showed 74% sensitivity and 49% specificity; Erythrocyte Sedimentation Rate (ESR) demonstrated 48% sensitivity and 72% specificity for GCA detection.
- Patients with normal inflammatory markers had a significantly longer duration between symptom onset and marker measurement (35 vs. 20 days).
- No significant differences in clinical presentation were observed between GCA patients with normal or elevated inflammatory markers.
Conclusions:
- GCA patients exhibit similar clinical presentations irrespective of their inflammatory marker status.
- A prolonged interval from symptom onset to inflammatory marker testing is associated with normal ESR and CRP levels in GCA.
- Low inflammatory marker levels should not deter a comprehensive diagnostic work-up for GCA.
More Related Videos
12:50Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies